Results 151 to 160 of about 18,650 (200)

Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial. [PDF]

Diabetes Care
Gisinger T, He JH, Oyeka CP, Ma J, Srialluri N, Woodward M, Michos ED, Kalyani RR, Clark JM, Kautzky-Willer A, Vaidya D, Bennett WL.   +11 more
europepmc   +1 more source

Early gestational prediction of spontaneous preterm birth using a validated three-protein serum biomarker panel. [PDF]

BMC Med
Luo Q, Wei J, Ding Y, Chen Y, Wu L, Chou CJ, Luo X, Ghafourian N, Tao J, Jin B, Su KJ, Mortensen RD, Schilling J, Han Z, Ozawa N, Ichikawa T, Luo RY, Sylvester KG, Ceresnak SR, Wong RJ, Tian L, Marić I, Aghaeepour N, Gaudilliere B, Angst MS, Shaw GM, McElhinney D, Cohen HJ, Darmstadt GL, Niu J, Stevenson DK, Ling XB.   +31 more
europepmc   +1 more source

Dihydroartemisinin for the treatment of polycystic ovary syndrome: study protocol for a multi-centre placebo-controlled randomised clinical trial. [PDF]

BMJ Open
Mu L, Shen Y, Wang G, Liu C, Yang H, Li W, Mol BW, Li X, Dong X, Jiang J.   +9 more
europepmc   +1 more source

Effectiveness of exercise interventions on androgen and sex hormone-binding globulin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis. [PDF]

Front Sports Act Living
Atmaca L, Chauhan S, Najaf SS, Elmadani M, Al-Jawarneh M, Soloh A, Varga Z, Vitrai J, Prémusz V.   +8 more
europepmc   +1 more source

Editorial: Polycystic ovarian syndrome in adolescence. [PDF]

Front Endocrinol (Lausanne)
Sharma R.
europepmc   +1 more source

Testosterone Replacement Therapy in Women Is Associated with Improved Symptom Burden and Favorable Biomarker Changes: A Retrospective Observational Study. [PDF]

J Pers Med
Elggren CW, Iverson CH, Morris MD, Cooper-Leavitt EF, Parker G, Richardson AW, Reynolds AP, Cortes PM, Bikman BT, Reynolds PR.   +9 more
europepmc   +1 more source

Outcome-specific shifts in homocysteine-androgen correlations in polycystic ovary syndrome. [PDF]

Front Endocrinol (Lausanne)
Han Q, Zhao J, Li M, Xin M, Yin X, He J.
europepmc   +1 more source

Higher Circulating Testosterone Linked to Higher CAD Risk in Men: Mendelian Randomization and Survival Analyses.

J Clin Endocrinol Metab
Morbey EJ, Day FR, Butterworth AS, Wareham NJ, Perry JRB, Ong KK.   +5 more
europepmc   +1 more source